NO996540D0 - Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo - Google Patents

Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo

Info

Publication number
NO996540D0
NO996540D0 NO996540A NO996540A NO996540D0 NO 996540 D0 NO996540 D0 NO 996540D0 NO 996540 A NO996540 A NO 996540A NO 996540 A NO996540 A NO 996540A NO 996540 D0 NO996540 D0 NO 996540D0
Authority
NO
Norway
Prior art keywords
tissues
vivo
transfer
nucleic acid
acid vectors
Prior art date
Application number
NO996540A
Other languages
English (en)
Other versions
NO996540L (no
Inventor
Michel Bureau
Lluis Mir
Daniel Scherman
Bertrand Schwartz
Original Assignee
Rhone Poulenc Rorer Sa
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708233A external-priority patent/FR2765242B1/fr
Priority claimed from FR9708232A external-priority patent/FR2765241B1/fr
Application filed by Rhone Poulenc Rorer Sa, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulenc Rorer Sa
Publication of NO996540D0 publication Critical patent/NO996540D0/no
Publication of NO996540L publication Critical patent/NO996540L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
NO996540A 1997-06-30 1999-12-29 Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo NO996540L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708233A FR2765242B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
FR9708232A FR2765241B1 (fr) 1997-06-30 1997-06-30 Amelioration du transfert d'acide nucleique dans les cellules d'organismes eucaryotes pluricellulaires et combinaison permettant la mise en oeuvre du procede
US6748797P 1997-12-01 1997-12-01
US6748897P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Publications (2)

Publication Number Publication Date
NO996540D0 true NO996540D0 (no) 1999-12-29
NO996540L NO996540L (no) 2000-02-03

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996540A NO996540L (no) 1997-06-30 1999-12-29 Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo

Country Status (11)

Country Link
EP (1) EP0993318A1 (no)
JP (1) JP2002515816A (no)
KR (1) KR20010014298A (no)
CN (1) CN1261812A (no)
AU (1) AU8730798A (no)
BR (1) BR9810500A (no)
CA (1) CA2295029A1 (no)
IL (1) IL133709A0 (no)
NO (1) NO996540L (no)
PL (1) PL337617A1 (no)
WO (1) WO1999001175A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
CA2361601A1 (en) * 1999-02-08 2000-08-10 Cheryl Goldbeck Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
EP1276500B1 (en) 2000-03-13 2011-06-08 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
AU5345901A (en) 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
AU6475901A (en) 2000-05-22 2001-12-03 Merck And Company Inc System and method for assessing the performance of a pharmaceutical agent delivery system
DE60144198D1 (de) 2000-12-28 2011-04-21 Wyeth Llc Rekombinantes schutzprotein aus streptococcus pneumoniae
ATE448793T1 (de) 2001-03-02 2009-12-15 Univ Rockefeller Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
JP2005518904A (ja) 2002-03-07 2005-06-30 マーク アンド カンパニー インコーポレイテッド 電気的刺激の側面を備えた臨床用注射器
WO2003100008A2 (en) 2002-05-24 2003-12-04 Schering Corporation Neutralizing human anti-igfr antibody
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (en) 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfer of nucleic acid into tissue cells
WO2007039799A2 (en) * 2005-10-03 2007-04-12 Novocure Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
JP4961137B2 (ja) * 2005-12-14 2012-06-27 久光製薬株式会社 イオントフォレーシス用デバイス
ES2388567T3 (es) 2006-10-19 2012-10-16 Csl Limited Anticuerpos anti-il-13r alfa 1 y usos de los mismos
WO2008060813A2 (en) 2006-10-19 2008-05-22 Merck & Co., Inc. High affinity antibody antagonists of interleukin-13 receptor alpha 1
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
DK2310500T3 (en) * 2008-07-18 2015-05-11 Maxcyte Inc Process for optimizing electroporation
NO2356135T3 (no) 2008-11-05 2018-03-24
WO2012025873A2 (en) 2010-08-23 2012-03-01 Wyeth Llc STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
PE20140173A1 (es) 2010-09-10 2014-02-20 Wyeth Llc Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
SG10201602558UA (en) 2012-03-09 2016-05-30 Pfizer Neisseria meningitidis compositions and methods thereof
WO2014107739A1 (en) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Antibodies against pcsk9
EP2964665B1 (en) 2013-03-08 2018-08-01 Pfizer Inc Immunogenic fusion polypeptides
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
BR112017017460A2 (pt) 2015-02-19 2018-04-10 Pfizer Inc. composições de neisseria meningitidis e métodos das mesmas
AU2018215585B2 (en) 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
WO1997007826A1 (en) * 1995-08-29 1997-03-06 Cbr Laboratories, Inc. In vivo electroporation of cells

Also Published As

Publication number Publication date
AU8730798A (en) 1999-01-25
PL337617A1 (en) 2000-08-28
BR9810500A (pt) 2000-09-05
KR20010014298A (ko) 2001-02-26
WO1999001175A1 (en) 1999-01-14
CN1261812A (zh) 2000-08-02
CA2295029A1 (en) 1999-01-14
NO996540L (no) 2000-02-03
IL133709A0 (en) 2001-04-30
EP0993318A1 (en) 2000-04-19
JP2002515816A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
NO996540D0 (no) Innretning for optimalisert elektrooverfoering av nukleinsyrevektorer til vev in vivo
DE69841895D1 (de) Nukleinsäuretestverfahren
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
NO970915D0 (no) Påvisning av hypermutabel nukleinsyresekvens i vev
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
AU8782198A (en) Highly sensitive multimeric nucleic acid probes
GB9710807D0 (en) Nucleic acid binding proteins
NO20011303D0 (no) FremgangsmÕter for nukleinsyreoppformering og sekvensering
EP1014790A4 (en) CHEMICAL MODIFICATION OF DNA USING PEPTIDE NUCLEIC ACID CONJUGATES
EP1027145A4 (en) APPARATUS AND METHODS FOR ISOLATING NUCLEIC ACID
DE1051515T1 (de) Modifizierte nuklein-säure sonden und dessen verwendungen
NO994009D0 (no) Gensekvensator og metoder
GB9717061D0 (en) Amplification of nucleic acids
GB9624165D0 (en) Use of nucleic acids bound to carrier macromolecules
EP1040200A4 (en) NUCLEIC ACIDS ASSOCIATED WITH VIRULENCE AND USE THEREOF
IL130886A0 (en) Nucleic acid sequencing
GB9717932D0 (en) Estimation of nucleic acid
IL123513A0 (en) Identification of bases in nucleic acid sequences
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
DE69840475D1 (de) Verbessertes fällungsverfahren von 7-aminocephalosporansäure
FR2777016B1 (fr) Silicone azotee utile pour compacter les sequences d'acides nucleiques et utilisation pour la transfection
NO20016089L (no) Nukleinsyrer og proteiner av det humane genet ABC1
GB0021008D0 (en) Protein and nucleic acid sequence
IL120283A0 (en) Nucleic acid sequences and proteins
SE9704063D0 (sv) Method and kit for nucleic ACID (PROBE) purification

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application